Ftse Mib
36.179,84
0,19%
DAX
21.394,93
-0,11%
S&P 500
6.094,13
-0,40%
NASDAQ
19.907,87
-0,73%
Bitcoin
106.324,07
2,27%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oramed Pharmaceuticals Inc (ORMP) Oramed Pharmaceuticals Inc (ORMP) Notizie

Oramed Pharmaceuticals Inc

ORMP
2,295
-0,005 (-0,22%)
Ultimo aggiornamento: 20:08:33
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/1/202515:18EDGAR2Form 8-K - Current report
17/1/202522:15EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202514:31EDGAR2Form 8-K - Current report
17/12/202422:55EDGAR2Form 8-K - Current report
08/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202422:01EDGAR2Form 8-K - Current report
08/10/202420:12EDGAR2Form 8-K - Current report
07/10/202416:00PRNUSOramed Pharmaceuticals Announces Restructuring of Scilex..
26/9/202422:05EDGAR2Form 8-K - Current report
23/9/202414:06EDGAR2Form 8-K - Current report
16/9/202422:42EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
02/8/202422:05EDGAR2Form 8-K - Current report
26/6/202415:05PRNUSOramed Letter to Shareholders
26/6/202415:00PRNUSOramed Pharmaceuticals Inc. Announces the Buy-Back of its..
20/6/202413:30EDGAR2Form DEF 14A - Other definitive proxy statements
10/6/202423:28EDGAR2Form 8-K - Current report
10/6/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202415:00EDGAR2Form 8-K - Current report
19/3/202414:00GLOBEScilex Holding Company Announces Repayment in Full of the..
06/3/202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202414:42EDGAR2Form 8-K - Current report
20/2/202414:30PRNUSOramed Letter to Shareholders
30/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,21 Min: 2,21 Max: 2,315
Chiusura: 2,30

La tua Cronologia

NASDAQ
ORMP
Oramed Pharmaceuticals
BIT
F06716
Vontobel Financial Produ...
BIT
SPST5S
Societe Generale Effekten
BIT
F19743
Vontobel Financial Produ...
BIT
Q00365
Leonteq Securities
BIT
1C3
C3ai
BIT
UC7T6E
Unicredit Bank
BIT
UB75Z9
Unicredit Bank
BIT
P1IDE0
BNP Paribas Issuance
NASDAQ
CLWT
Euro Tech
BIT
F14165
Vontobel Financial Produ...
BIT
Q00112
Leonteq Securities
BIT
UI419X
UniCredit
BIT
F37678
Vontobel Financial Produ...
BIT
Q00537
Leonteq Securities
BIT
UC20PM
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network